Heart failure module 3: pharmacological management

Released1 November 2017     Expires: 01 November 2019      Programme: Heart failure 2 CPD/CME credits

Sponsorship Statement: Vifor Pharma UK has provided an unrestricted grant to fund this activity and has not had any input into any aspect of this learning resource. The original module was supported by an educational grant from Pfizer UK and Servier Laboratories Ltd.

Designed to give healthcare professionals an understanding of the non-pharmacological and pharmacological management of heart failure, it is one of several modules in our heart failure programme.

Module first published: 23 September 2014
Revised module released: 01 November 2017

Learning objectives

After completing this module, participants should be better able to:

  • Understand the aims of heart failure (HF) treatment
  • Recognise the role of the primary care team in HF management
  • Recognise the role of lifestyle modifications (weight control, smoking cessation, exercise)
  • Understand the treatment options available for acute and chronic HF
  • Understand the modes of action of the different therapeutic agents prescribed

Faculty

Professor Andrew Clark, Chair in Clinical Cardiology, Hull York Medical School
Dr Paul Kalra, Consultant Cardiologist, Portsmouth Hospitals NHS Trust
Dr Donah Zachariah, Cardiology Research Fellow, Portsmouth Hospitals NHS Trust

Module revised by Dr Joe Cuthbert, Clinical Research Fellow, Hull York Medical School, in collaboration with Andrew Clark

Accreditation

2 CPD/CME credits, 2 hours
BJC Learning has assigned two hours of CPD/CME credit to this module

Endorsed by:

You need to login to take this module

You need to be a registered member to view this page. It's quick, free and offers you a host of other benefits, including the facility to print and download articles and supplements, access our archived issues and receive email updates when new issues and other content are online.

6 thoughts on “Heart failure module 3: pharmacological management”

All rights reserved. No part of this programme may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior permission of the publishers, Medinews (Cardiology) Limited.

It shall not, by way of trade or otherwise, be lent, re-sold, hired or otherwise circulated without the publisher’s prior consent.

Medical knowledge is constantly changing. As new information becomes available, changes in treatment, procedures, equipment and the use of drugs becomes necessary. The editors/authors/contributors and the publishers have taken care to ensure that the information given in this text is accurate and up to date. Readers are strongly advised to confirm that the information, especially with regard to drug usage, complies with the latest legislation and standards of practice.

Healthcare professionals should consult up-to-date Prescribing Information and the full Summary of Product Characteristics available from the manufacturers before prescribing any product. Medinews (Cardiology) Limited cannot accept responsibility for any errors in prescribing which may occur.